KLOW Side Effects and Safety: What’s Known and What Isn’t

Reviewed by Thomas Okafor, Peptide Chemist · Updated October 2026

The most commonly reported KLOW side effects are injection-site redness or soreness, fatigue, headache, nausea and flushing. These reports come from users and clinics, not studies: KLOW has never been safety-tested in humans, and its biggest risks may come from contamination or mislabeled vials.

That second sentence is the one to hold on to. When people search for KLOW peptide side effects, they usually find a tidy bulleted list and assume someone measured it. Nobody did. What exists is a patchwork: a few small human studies on single ingredients, a lot of animal work, forum posts, clinic observations, and a growing body of lab testing on the vials themselves. This guide sorts those pieces by how much weight each can bear, so you can see what’s actually known about KLOW’s safety, what’s guesswork, and where the real dangers are likely to come from. For background on KLOW itself, see what the KLOW stack is.

KLOW is sold for research use only. This page is educational and isn’t medical advice; see our Medical Disclaimer. If you’re dealing with symptoms right now, jump to the warning signs section.

Is KLOW Safe?

No one can say KLOW is safe, because it has never been through a human safety trial. Each of its four peptides lacks long-term human data, the blend itself is untested, and products are sold as “research use only” with no required quality standards. “Generally safe” claims from clinics aren’t based on studies.

It helps to know what a real safety trial looks like, because that’s the yardstick. Before a drug reaches a pharmacy shelf, researchers give it to small groups at carefully stepped amounts, draw blood to watch the liver, kidneys and blood counts, record every adverse event (even ones that seem unrelated), and then follow larger groups for months or years. KLOW has had none of that. The closest thing on record for any ingredient is a 2025 pilot study in which two adults received BPC-157 through an IV over three days, with no changes in standard blood tests. Two people over three days is a starting point. It can’t speak to rare reactions, months of exposure, or three other peptides in the same vial.

You’ll often hear that GHK-Cu and KPV are “natural” because versions of them occur in the body. That’s true, and it’s also beside the point. Your body makes adrenaline and insulin too, and both are dangerous in the wrong amount or the wrong place. A synthetic copy, made in a factory, dissolved and injected at amounts far above what circulates naturally, is a different situation from the trace levels in your bloodstream.

Medical groups have been saying this plainly. The American Medical Association’s April 2026 guidance quotes sports medicine physician Dr. Anthony Tam, who notes that “there’s still a lot we don’t know” about newer injectable peptides. Harvard Health, in an article reviewed by Harvard Medical School’s Dr. Pieter Cohen, says experts don’t know enough about injectable peptides to predict their effects.

What about the question of which peptides are the safest? Outside of approved medicines like insulin and the GLP-1 drugs, which went through full trials, no peptide has an established safety profile. Some simply have more data than others.

Common KLOW Side Effects (Reported by Users)

Users and clinics most often report mild, short-lived effects: redness, itching, swelling or a warm bump at the injection site; tiredness; headache; nausea; flushing; and dizziness. These come from anecdotes and clinic observations, so how often they happen, and whether KLOW causes them, is unknown.

This list lines up with what Harvard Health and the AMA describe for injectable peptides in general: injection-site irritation, stomach upset, headache and fatigue. That overlap tells you something useful. Many of these effects may come from the act of injecting, or from what’s in a typical gray-market vial, more than from any one KLOW ingredient.

You’ll notice the “how often” column uses words, with no percentages. That’s deliberate, and the reason is below.

On Reddit, KLOW side effects threads tend to circle the same handful of complaints, with tiredness leading the pack. One r/BodyHackGuide poster described feeling “extremely tired” two weeks in. A thread titled “What side effects made you stop?” gathers similar stories. These posts are genuinely useful as an early signal, much like the first few customer reviews on a new product. They’re also unverified, and nobody knows how many people felt fine and never posted, or how many felt bad for reasons unrelated to KLOW.

Why does KLOW make some people tired?

Users commonly report fatigue, but there’s no studied mechanism behind it. A few explanations are plausible: the immune system reacting to something in the vial, bacterial toxins (endotoxins) that can cause flu-like tiredness, copper effects, or plain coincidence, since fatigue is common in everyday life. Without a controlled study, there’s no way to know which applies. Tiredness that sticks around is worth a visit to a clinician, who can check bloodwork and look for other causes.

Ignore side-effect percentages

Some websites state that a certain share of “research subjects” get injection-site reactions or other effects. No study of KLOW exists, so there are no subjects to count. Any percentage you see for KLOW side effects was invented, borrowed from an unrelated drug, or guessed. Treat it like a weather forecast for a city that doesn’t exist.

KLOW Side Effects by Ingredient

Each KLOW peptide brings its own open questions. GHK-Cu adds copper, BPC-157 and TB-500 promote blood-vessel growth and cell migration (raising theoretical cancer concerns), and KPV’s effects on the immune system haven’t been studied in people.

GHK-Cu (50 mg)

GHK-Cu makes up 50 of the vial’s 80 milligrams, and it’s a copper complex, so copper comes along with every bit of it. Your body needs a trace of copper, and the liver tucks away whatever extra arrives, which can harm it over time. A September 2026 NPR investigation included a doctor’s account of patients with raised liver enzymes, high copper in the blood and infected injection sites after using copper peptides ordered online, often in larger amounts than they’d intended. Topical GHK-Cu, which has the most human research, can cause skin irritation in some people. Anyone with Wilson’s disease or another copper-handling disorder faces the clearest risk, since their bodies already struggle to clear copper. More detail is in our GHK-Cu side effects guide.

BPC-157 (10 mg)

BPC-157 is studied mainly for its effects on angiogenesis, the growth of new blood vessels. That’s helpful for a healing tendon. It also raises a fair question, because tumors need new blood vessels too. No study shows BPC-157 causes or speeds cancer, and no study has looked. Animal toxicity work, including a 2020 preclinical safety evaluation, didn’t find major organ damage, but there’s no human liver or kidney data beyond the two-person IV pilot. A 2025 systematic review found the evidence base almost entirely preclinical. Our BPC-157 side effects guide covers the details.

TB-500 (10 mg)

TB-500 is a lab-made piece of thymosin beta-4 (Tβ4), the body’s own cell-mobility and vessel-building protein. Cancer researchers have noticed that some tumors carry unusually high amounts of it. In head and neck cancers, a 2017 Scientific Reports study found the Tβ4 gene ranked among the most overactive, and patients with higher levels tended to do worse. That’s an observation about tumor tissue. It says nothing direct about whether TB-500 can start or feed a cancer. It’s still why some clinicians advise people with any cancer history to avoid it. See our TB-500 side effects guide.

KPV (10 mg)

KPV is a tiny tripeptide, just the last three building blocks of the hormone alpha-MSH, and it quiets inflammatory signals in mouse colitis studies. Turning down immune signals sounds appealing, but the immune system also fights infections and keeps an eye out for abnormal cells. No one has studied what KPV does in people with autoimmune disease, or alongside immune-suppressing medicines. More is in our KPV guide and the KPV side effects page.

KLOW Risks of the Blend Itself

Mixing four peptides in one vial adds risks none of them has alone. There’s no published data on their stability together, the peptides clear the body at different speeds, sellers list different contents, and if a reaction happens there’s no way to tell which ingredient caused it. The shared-vial stability question applies only to the premixed KLOW blend; a KLOW stack keeps each peptide in its own vial with its own label, though the other unknowns stay the same.

Think of a four-ingredient casserole that leaves someone queasy. Was it the shrimp, the cream, the cheese, or the fact that it sat on the counter too long? With a single ingredient you’d have a decent guess. With four, you’re stuck. That’s the core problem of any blend, and KLOW adds a few twists of its own:

• Stability: Forum posters often argue that, once mixed with water, the copper in GHK-Cu breaks down its vial-mates. Since copper can react with some amino acids, the idea isn’t far-fetched. It also hasn’t been tested in any published study.
• Mismatched clearance times: Each peptide is thought to leave the body at a different pace. One clinic summed it up with the observation that the peptides run on schedules a single blended vial can’t follow. One vial means one schedule for all four, whether or not that makes chemical sense.
• Labels that disagree: Sellers don’t always list the same amounts, and some don’t list them at all. Two vials both called “KLOW” may not contain the same thing.
• No way to pin down a cause: If a rash or a fever appears, a doctor can’t tell which of four peptides, or which impurity, triggered it.
• More ingredients, more impurities: Every peptide is made separately and brings its own manufacturing byproducts. Four peptides means four chances for something unwanted to ride along.

Is KLOW riskier than GLOW?

KLOW is GLOW with KPV added, so it carries one more unknown, especially around immune effects. No study has compared the two blends, so there’s no data showing either one is safer. If you want the side-by-side breakdown, see KLOW vs GLOW. The same logic answers questions about side effects of glow peptide stacking: each added ingredient adds its own open questions to the pile.

The Biggest Real-World Risk: Product Quality

Because KLOW is sold as a “research chemical”, nothing guarantees what’s in the vial. Independent tests of research peptides have found wrong amounts, missing ingredients, impurities and bacterial toxins. Contamination can cause infections, abscesses and severe reactions unrelated to the peptides themselves.

This is where the hard numbers are, and they’re sobering. In an April 2026 preprint, sports medicine researchers Christopher Mendias and Tariq Awan analyzed 6,441 independent lab results for gray-market peptides, covering 14 compounds including BPC-157, GHK-Cu, TB-500 and thymosin beta-4. Depending on which quality standard they applied, 41.6% to 71.1% of samples failed basic quality criteria, and measurable endotoxin turned up in 15% of samples. The study hasn’t been peer-reviewed yet, and it didn’t test KLOW specifically, but it’s the largest look at research peptide quality published so far.

Here’s what can go wrong between the factory and the vial:

• Sterility: Injectable medicines are made in sterile conditions. Research powders have no such requirement, and bacteria in a vial can cause abscesses or a bloodstream infection.
• Endotoxin: These are fragments of bacterial cell walls. Even when the bacteria are dead, endotoxins can cause fever, chills and flu-like crashes. A high-purity reading on a lab report doesn’t rule them out.
• Heavy metals and solvents: Leftovers from manufacturing that a standard purity test isn’t designed to catch.
• Wrong amounts: Under-filled or over-filled vials. With KLOW’s copper load, an overfilled vial is a bigger deal than it would be for most single peptides.
• Counterfeits: A vial labeled KLOW that contains something else entirely.

Live Science reported in July 2026 that many of these peptides are ordered from overseas, usually from China. Purity, dosing consistency and quality control were described by a physician in that piece as among the biggest concerns.

What about KLOW offered by telehealth companies as a compounded prescription? That legal ground is unsettled. In 2023, the FDA placed BPC-157, GHK-Cu, KPV and several others on a list of substances that may pose serious safety risks in compounding. Several, including BPC-157 and TB-500, came off that list in April 2026, and an advisory panel voted for three KLOW ingredients in July 2026. As of October 2026, though, none is on the approved compounding list, and injectable GHK-Cu wasn’t part of the July review. A compounded four-peptide KLOW product has no clear legal basis right now.

How to read a KLOW COA

A certificate of analysis (COA) is a lab report for a specific batch. For a four-peptide blend, a credible one shows:

• Identity and amount for all four peptides, confirmed by HPLC plus mass spectrometry
• A purity figure for each peptide
• Endotoxin and sterility results (often missing, and the most important ones for an injectable)
• A batch or lot number that matches the vial label
• A named third-party lab and a test date

A COA with only one peptide listed, no lab name, or a batch number that doesn’t match is a red flag. Our KLOW COA guide walks through a sample report line by line.

Long-Term Side Effects: What We Don’t Know

Long-term effects of KLOW are completely unknown. No study has followed people using any of its four injected peptides for months or years. The main theoretical concerns are effects on tissue growth (cancer), copper buildup, immune changes, and repeated exposure to impurities.

It’s worth pausing on why “unknown” is different from “fine.” Plenty of medicines looked harmless in short studies and revealed problems only after years of wide use. That’s exactly why approved drugs keep being monitored after launch. Long-term side effects of peptides in general follow the same rule: the approved ones have years of follow-up data, and the research ones have essentially none.

For KLOW, the long-term questions fall into four buckets. First, tissue growth: two ingredients promote new blood vessels and cell movement, and nobody knows what years of that signal would do. Second, copper: the liver stores excess copper slowly, so problems could build quietly over time. Third, the immune system: repeated exposure to foreign or impure material can, in some people, set off allergic or autoimmune responses, a risk Harvard Health flags for injectable peptides broadly. Fourth, impurities: even small amounts of endotoxin or metals add up across repeated exposures.

None of these is proven. All of them are open.

Who Should Avoid KLOW?

People who should not use KLOW include anyone who is pregnant or breastfeeding, has active cancer or a cancer history, has a copper-metabolism disorder like Wilson’s disease, has an autoimmune condition or takes immunosuppressants, is under 18, or competes in drug-tested sport.

Here’s the reasoning behind each group, plus a few more:

• Pregnant or breastfeeding: No KLOW ingredient has any safety data in pregnancy or nursing.
• Active cancer or a cancer history: Two ingredients promote blood-vessel growth, and Tβ4 is linked to some tumors in tissue studies.
• Wilson’s disease or other copper disorders: GHK-Cu adds copper the body may not be able to clear.
• Autoimmune conditions or immunosuppressant medicines: KPV’s immune effects have never been studied in these situations.
• Under 18: Growing bodies, zero data.
• Drug-tested athletes: Two ingredients are on the WADA banned list (more below).
• Heart disease or uncontrolled blood pressure: Flushing and dizziness reports, plus no cardiovascular data.
• Liver disease: Copper is processed by the liver, and liver enzyme rises have been reported with injected copper peptides.
• Known peptide allergies: Higher chance of a serious reaction.
• Upcoming surgery: Unknown effects on bleeding and healing. Tell your surgeon about anything you’ve taken, the same way you’d mention supplements like fish oil.

This list marks the groups with the most obvious extra risks. It isn’t a green light for everyone else; for everyone, the safety data is missing.

KLOW side effects in women vs men

There’s no sex-specific safety data for KLOW or its ingredients. Online, women’s posts tend to focus on skin and men’s on recovery, but the unknowns are the same for both. Pregnancy and fertility are open questions, since no ingredient has been studied for either.

Athletes

BPC-157 is banned under WADA’s S0 class for unapproved substances, and TB-500 under S2. GHK-Cu and KPV aren’t named on the list, but S0 covers any unapproved substance, so a tested athlete should check with their anti-doping body before going near any of them.

Warning Signs: When to Get Medical Help

Seek urgent care for signs of a severe allergic reaction (swelling of the face, lips or throat, trouble breathing, widespread hives), or of infection (spreading redness, heat, pus, fever). Also see a doctor for severe or lasting fatigue, yellowing skin or eyes, dark urine, or new lumps.

Call 911 or go to the ER for:

• ☐ Swelling of the face, lips, tongue or throat
• ☐ Trouble breathing or wheezing
• ☐ Widespread hives, or feeling faint
• ☐ Fever with chills and a racing heart
• ☐ Redness that spreads quickly from the injection site

Book a doctor’s visit soon for:

• ☐ Fatigue that lasts more than a few days
• ☐ Yellowing skin or eyes, or dark urine
• ☐ A lump, hard knot or pus at the injection site
• ☐ Ongoing nausea, headaches or dizziness
• ☐ Any new lump elsewhere on the body

Bring with you: the vial, its label, and any COA or batch number. Doctors can treat you better when they know what they’re dealing with, and they aren’t there to judge.

Serious reactions do get reported online. A widely discussed r/PeptidePathways thread, with more than 80 comments, described an emergency room visit and a rheumatology workup after using a KLOW-type blend. One anecdote can’t establish cause, but it’s a reminder that these aren’t hypothetical worries.

How to report a reaction: The FDA collects reports of problems with any medical product, including unapproved ones, through MedWatch. Patients and doctors can both file. These reports are how regulators spot patterns, and with no clinical trials of KLOW, they’re one of the few safety signals available.

Is KLOW Legal for Human Use?

No. KLOW isn’t FDA-approved for any use, and research-grade vials are labeled “not for human consumption”. Three of its peptides (BPC-157, TB-500, KPV) got a favorable FDA advisory vote for compounding in July 2026, but rulemaking is pending, and GHK-Cu wasn’t reviewed.

The July 23, 2026 Pharmacy Compounding Advisory Committee vote was 8 to 6, with one abstention. Harvard Health noted that a recommendation is not a decision: the FDA still has to publish a proposed rule and take public comment. Even if all three ingredients are eventually added, that would allow pharmacies to compound them with a prescription. It wouldn’t make KLOW an approved drug, and it wouldn’t cover GHK-Cu as an injectable.

The “research use only” label is what lets these products be sold legally in the US, and it’s also the reason no one checks them like medicines. For the full picture, see what the KLOW stack is and our guide to whether research peptides are legal.

Frequently Asked Questions

What are the most common KLOW side effects?

The most commonly reported KLOW side effects are injection-site redness, swelling or soreness, fatigue, headache, nausea and flushing. All come from user and clinic reports. No study has measured how often they happen.

Is KLOW safe?

KLOW’s safety in humans is unknown. It has never been through a human safety trial, its four ingredients lack long-term human data, and research vials have no required quality standards.

Why does KLOW make me tired?

No one knows. Fatigue is a common report, and possible causes include an immune response, endotoxin contamination, copper effects or coincidence. Lasting tiredness deserves a check with a clinician.

Can KLOW cause cancer?

There’s no evidence KLOW causes cancer. The concern is theoretical: BPC-157 and TB-500 promote blood-vessel growth, and Tβ4 is linked to some tumors in tissue studies. Nobody has studied it directly.

Can KLOW cause an allergic reaction?

Yes, as with any injected product. Signs include hives, swelling of the face or throat, and trouble breathing. A severe reaction is a medical emergency, so call 911.

Does KLOW affect the liver?

It might. GHK-Cu carries copper, which the liver stores, and NPR reported raised liver enzymes and high copper in people self-injecting copper peptides. No liver study of KLOW exists.

What are the long-term side effects of KLOW?

They’re unknown. No one has followed people using KLOW or its injected ingredients for months or years. Theoretical concerns include tissue growth, copper buildup, immune changes and impurities.

Who should not take KLOW?

Higher-risk groups include people who are pregnant or breastfeeding, have a cancer history, have Wilson’s disease, have autoimmune conditions, are under 18, or compete in tested sport. Safety data is missing for everyone.

Is KLOW safer than GLOW?

There’s no data either way. KLOW adds KPV to GLOW, so it carries one more ingredient and one more set of unknowns, particularly around the immune system.

Is KLOW legal for human use?

No. KLOW isn’t FDA-approved, and research vials are labeled not for human consumption. A July 2026 advisory vote favored three ingredients for compounding, but no rule is final.

What should I do if I have a reaction to KLOW?

For trouble breathing, facial swelling or a spreading infection, call 911. For milder but lasting symptoms, see a doctor and bring the vial and label. You can report the reaction to FDA MedWatch.

Disclaimer: KLOW and its ingredients are sold for research use only and aren’t approved for human use. This page is educational, doesn’t give medical advice, and isn’t a substitute for care from a licensed clinician. Read our Medical Disclaimer and Editorial Policy.